Lv5
978 积分 2023-06-15 加入
Nivolumab plus docetaxel versus placebo plus docetaxel for androgen receptor pathway inhibitor-pretreated and chemotherapy-naive metastatic castration-resistant prostate cancer (CheckMate 7DX): a double-blind, randomised, phase 3 trial
7小时前
待确认
Patient-reported Outcomes in KEYNOTE-921: Pembrolizumab with Docetaxel and Prednisone for Patients with Metastatic Castration-resistant Prostate Cancer
8小时前
待确认
Cancer burden and control in China: landscape, trends and challenges
10天前
已完结
Personalized and HPV cancer vaccines in head and neck squamous cell carcinoma: from concept to clinical implementation
23天前
已完结
Management approaches for recurrent or metastatic head and neck squamous cell carcinoma after anti-PD-1/PD-L1 immunotherapy
24天前
已完结
The role of systemic therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma progressed to immunotherapy: A systematic review and meta analysis
24天前
已完结
Novel Combination Immunotherapy and Clinical Activity in Patients With HPV-Associated Cancers
27天前
已完结
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
1个月前
已完结
Glasdegib in combination with temozolomide and radiotherapy in adult patients with newly diagnosed glioblastoma: the phase Ib/II GEINO 1602 trial
1个月前
已完结
Abstract 7871: Onvansertib-mediated PLK1 inhibition reduces cell viability in neuroblastoma cells
1个月前
已关闭
皖公网安备34019202002308
